President and CEO
Jeremy Maniak joined Minnetronix in 2010, and was named Chief Operating Officer in 2013. He assumed the role of President in April 2017 and was named CEO in 2020. Jeremy is a named inventor on ten patents, combined issued and filed, and has extensive experience in the development and commercialization of medical products including active implantable devices.
Before joining Minnetronix, Jeremy was Vice President of Research at Leptos Biomedical where he led clinical and preclinical efforts to develop neuromodulation therapy for the treatment of obesity and type 2 diabetes. His experience also includes working as a Principal Engineer and Senior Manager in research and development at Guidant Corporation/Boston Scientific in developing implantable devices that treat cardiac dysrhythmias and heart failure.
Jeremy received a Bachelor of Science in Electrical Engineering and a Master of Science in Electrical Engineering from Purdue University. He also earned his Master of Business Administration from the University of Minnesota.